CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK, Jan MUŽÍK, M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER a H. BRENNER. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncology. New York: Elsevier Science INC, 2021, roč. 22, č. 7, s. 1002-1013. ISSN 1470-2045. Dostupné z: https://dx.doi.org/10.1016/S1470-2045(21)00199-6.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
Autoři CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK (203 Česká republika, domácí), Jan MUŽÍK (203 Česká republika, domácí), M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER a H. BRENNER (garant).
Vydání Lancet Oncology, New York, Elsevier Science INC, 2021, 1470-2045.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30204 Oncology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 54.433
Kód RIV RIV/00216224:14110/21:00121970
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/S1470-2045(21)00199-6
UT WoS 000668269600045
Klíčová slova anglicky colorectal cancer; incidence; mortality; stage distribution; Europe
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 23. 7. 2021 13:32.
Anotace
Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.
VytisknoutZobrazeno: 25. 4. 2024 11:53